The WHO Clinical Staging System for HIV/AIDS allows physicians in resource-limited settings to make clinical decisions based on patient clinical features instead of laboratory tests.
There are U.S. regulations on drug sales by Internet pharmacies; there is a need to make life-sustaining drugs available at prices more people can afford.
Does a surgeon’s complication rate in a randomized controlled trial constitute a “significant new finding” that must be reported to patients during the consent process?
Dr Majd Alsoubani joins Ethics Talk to discuss her article, coauthored with Drs Maya Nadimpalli and Shira Doron: "How Should Health Care Respond to Threats Antimicrobial Resistance Poses to Workers?”